30% Levered FCF Yield but Bad Balance Sheet, Bad Business?
A closer look reveals a hidden oligopoly and a faster path to delever than the market thinks.
Most investors hear “commodity business” and stop reading. That’s the mistake here.
In this case, we have a commodity business with an ugly balance sheet. Sounds horrible, right? That’s exactly why the opportunity exists.
But taking a closer look reveals:
The external headwinds that crushed 2025 have fully reversed into tailwinds. Management’s 2026 EBITDA guidance midpoint of $160M essentially matches 2023’s $162M — a level the current market cap doesn’t reflect.
Cash flow from 2026 plus some announced asset sales should be sufficient to put the balance sheet into a healthy position by year-end.
Despite being a commodity business, it operates in a regional oligopoly and the local regulator itself has formally described the company as exhibiting “features of a monopoly player” in its core market. The next meaningful competitor sits 600+ km away.
With most of the EBITDA flowing to debt repayment, the company currently trades at a levered FCF yield of ~30% for 2026.
Three catalysts beyond earnings: asset sales, capital structure simplification, idle asset restarts.
The stock is…